Fig. 2 From: Diagnostic characteristics, treatment patterns, and clinical outcomes for patients with advanced/metastatic medullary thyroid cancerProgression-Free Survival A. Overall Population, First-Line Therapy. B. RET-Mutant Medullary Thyroid Cancer, First-Line Therapy. C. Overall Population, Second-Line Therapy. CI confidence interval, MTC medullary thyroid cancer, NE not estimable, PFS progression-free survival, RET rearranged during transfection, SE standard errorBack to article page